sb 203580 has been researched along with Absence Status in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, Y; Feng, Z; Huang, H; Peng, Y; Wang, J; Xu, Z; Zeng, J; Zhang, H; Zhang, J; Zhou, X | 1 |
| Corcoran, ME; Ji, SP; Jiang, W; Saucier, DM; Sheerin, AH; Van Cleemput, J; Zhang, X; Zhang, Y | 1 |
2 other study(ies) available for sb 203580 and Absence Status
| Article | Year |
|---|---|
Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1.
Topics: Animals; Anticonvulsants; Brain; Epilepsy; Equilibrative Nucleoside Transporter 1; Glutamic Acid; Hippocampus; Imidazoles; Male; Neurons; p38 Mitogen-Activated Protein Kinases; Pilocarpine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Seizures; Signal Transduction; Status Epilepticus | 2020 |
Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance.
Topics: Animals; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; Imidazoles; Male; MAP Kinase Signaling System; Nerve Degeneration; Neurons; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Inbred F344; Status Epilepticus | 2005 |